Literature DB >> 6411711

Distinct patterns of cytoplasmic protein phosphorylation related to regulation of synthesis and release of prolactin by GH cells.

A Sobel, A H Tashjian.   

Abstract

The actions of thyrotropin-releasing hormone (TRH) on protein phosphorylation in the GH4C1 clonal strain of rat pituitary cells were examined by two-dimensional polyacrylamide gel electrophoresis and related to the ability of this tripeptide to stimulate prolactin (PRL) synthesis and release, respectively. Between 2 and 10 min after addition of the hormone, TRH increased the rate of phosphorylation of a small number of specific cytoplasmic proteins. The dose-response characteristics for TRH-induced protein phosphorylation were closely similar to those for its biological actions (ED50 congruent to 2 nM). TRH did not stimulate protein phosphorylation in the related GH12C1 cell strain which lacks TRH receptors. The proteins modified by TRH treatment were present in low amounts in the cell; they were not detectable by silver staining of the gels, except for protein 1 (Mr = 80,000) whose TRH-induced conversion from its unphosphorylated to its more acidic phosphorylated form was observed directly on silver-stained gels. Two distinct sets of phosphoproteins were identified among the seven affected by TRH: set I, five proteins whose phosphorylation was increased only by agents which stimulated PRL synthesis; and set II, two proteins whose phosphorylation was also increased by vasoactive intestinal peptide, which stimulates PRL release but not its synthesis in GH4C1 cells. This distinction between phosphoproteins related either to the release or synthesis of PRL was substantiated further by the use of an analog of TRH, A42658, which stimulated PRL synthesis and phosphorylation of proteins of set I at a lower concentration (0.2-0.5 microM) than was required to stimulate PRL release and phosphorylation of proteins of set II (greater than 0.5 microM). Finally, pretreatment of the cells with 1 mM ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid, which prevents TRH-induced PRL release but not synthesis, also suppressed TRH-stimulated phosphorylation of proteins of set II, but not of set I. These results relate stimulation by TRH of the phosphorylation of two distinct sets of proteins to the two major biological action of TRH in GH4C1 cells; proteins of set I appear to be related to the regulation of PRL synthesis, whereas those of set II appear related to modulation of PRL release.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411711

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders.

Authors:  Aixiao Liu; Christine Stadelmann; Mario Moscarello; Wolfgang Bruck; Andre' Sobel; Fabrizio G Mastronardi; Patrizia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

2.  Temporal patterns of protein phosphorylation after angiotensin II, A23187 and/or 12-O-tetradecanoylphorbol 13-acetate in adrenal glomerulosa cells.

Authors:  P Q Barrett; I Kojima; K Kojima; K Zawalich; C M Isales; H Rasmussen
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

3.  Phosphorylation of stathmin modulates its function as a microtubule depolymerizing factor.

Authors:  F J Moreno; J Avila
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

4.  Predominant expression of type II vasoactive intestinal peptide receptors by human T lymphoblastoma cells: transduction of both Ca2+ and cyclic AMP signals.

Authors:  M Xia; S P Sreedharan; E J Goetzl
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

5.  Ca2+-dependent phosphorylation by endogenous kinases of Mr 95 K and 50 K-55 K proteins in PC12 pheochromocytoma cells.

Authors:  K Okumura-Noji; T Kato; R Tanaka
Journal:  Neurochem Res       Date:  1986-11       Impact factor: 3.996

6.  Regulation of protein kinase C by extracellular calcium in bovine parathyroid cells.

Authors:  N Kobayashi; J Russell; D Lettieri; L M Sherwood
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

7.  Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.

Authors:  Shuai Wang; Javed Akhtar; Zhou Wang
Journal:  Tumour Biol       Date:  2015-05-06

8.  The interaction of lithium with thyrotropin-releasing hormone-stimulated lipid metabolism in GH3 pituitary tumour cells. Enhancement of stimulated 1,2-diacylglycerol formation.

Authors:  A H Drummond; C A Raeburn
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

9.  Thyrotropin-releasing hormone stimulates GTP hydrolysis by membranes from GH4C1 rat pituitary tumor cells.

Authors:  P M Hinkle; W J Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

10.  Defective thyroliberin-induced prolactin synthesis and release in a hybrid GH strain.

Authors:  B A Brennessel; D K Biswas
Journal:  Mol Cell Biochem       Date:  1984-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.